Literature DB >> 19459766

Predictors of parental interest in continuous glucose monitoring for children with type 1 diabetes.

Laurissa Kashmer1, William Clarke, Matthew Gurka, Swati Elchuri, Maren Nyer, Linda Gonder-Frederick.   

Abstract

BACKGROUND: Optimal control of type 1 diabetes (T1D) in children minimizes long-term complications, but increases hypoglycemic events. A continuous glucose monitor (CGM) can provide real-time information about glucose levels and trends. Little has been published on the characteristics of patients most willing to use CGM.
METHODS: Online survey software was utilized to administer a 50-item questionnaire to parents of children with T1D. The primary outcome was whether the parent expressed a high level of interest in CGM. The proportion of parents who expressed a high level of interest was compared across demographic and clinical variables via chi(2) tests (alpha = 0.05).
RESULTS: Analysis was performed on 457 surveys. The mean +/- SD age of the children was 10 +/- 4.1 years. Mean reported hemoglobin A1c (HbA1c) was 7.8 +/- 1.3%. Of the respondents, 70% used continuous subcutaneous insulin infusion (CSII). Parents reported an average of eight blood glucose (BG) checks daily. Over 90% of the parents indicated a high level of interest in having their child use a CGM. Primary variables related to interest in a CGM were use of CSII (P = 0.002), checking BG more than six times daily (P = 0.005), and parental worry about high or low BG (P = 0.0012 and P = 0.02, respectively). Age of the child and HbA1c were not related to parental interest in a CGM.
CONCLUSIONS: Overall parental interest in CGM was high. Use of CSII, frequent BG checks, and parental worry, but not age of the child or diabetes control, were associated with parental interest in using a CGM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19459766      PMCID: PMC2902231          DOI: 10.1089/dia.2008.0100

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  20 in total

1.  How acceptable are innovative health-care technologies? A survey of public beliefs and attitudes in England and Wales.

Authors:  Michael Calnan; David Montaner; Rob Horne
Journal:  Soc Sci Med       Date:  2004-11-13       Impact factor: 4.634

Review 2.  Glycemic variability: it's not just about A1C anymore!

Authors:  Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2005-10       Impact factor: 6.118

3.  A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes.

Authors:  H Peter Chase; Roy Beck; William Tamborlane; Bruce Buckingham; Nelly Mauras; Eva Tsalikian; Tim Wysocki; Stuart Weinzimer; Craig Kollman; Katrina Ruedy; Dongyuan Xing
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

4.  Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications.

Authors:  Michael Brownlee; Irl B Hirsch
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

5.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

6.  Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

Authors:  Satish Garg; Howard Zisser; Sherwyn Schwartz; Timothy Bailey; Roy Kaplan; Samuel Ellis; Lois Jovanovic
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

7.  The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes.

Authors:  Darrell M Wilson; Roy W Beck; William V Tamborlane; Mariya J Dontchev; Craig Kollman; Peter Chase; Larry A Fox; Katrina J Ruedy; Eva Tsalikian; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

8.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

Authors:  Louis Monnier; Emilie Mas; Christine Ginet; Françoise Michel; Laetitia Villon; Jean-Paul Cristol; Claude Colette
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

9.  Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes.

Authors: 
Journal:  Pediatr Diabetes       Date:  2006-02       Impact factor: 4.866

10.  FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group.

Authors:  Stuart Weinzimer; Dongyuan Xing; Michael Tansey; Rosanna Fiallo-Scharer; Nelly Mauras; Tim Wysocki; Roy Beck; William Tamborlane; Katrina Ruedy
Journal:  Diabetes Care       Date:  2007-12-20       Impact factor: 19.112

View more
  4 in total

1.  Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.

Authors:  Gabriela H Telo; Lisa K Volkening; Deborah A Butler; Lori M Laffel
Journal:  Diabetes Technol Ther       Date:  2015-03-06       Impact factor: 6.118

Review 2.  Closed-loop glucose control: psychological and behavioral considerations.

Authors:  Linda Gonder-Frederick; Jaclyn Shepard; Ninoska Peterson
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

Review 3.  Quality of life and technology: impact on children and families with diabetes.

Authors:  Masakazu Hirose; Elizabeth A Beverly; Katie Weinger
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

4.  Recruitment Into a Pediatric Continuous Glucose Monitoring RCT.

Authors:  Lisa K Volkening; Kaitlin C Gaffney; Michelle L Katz; Lori M Laffel
Journal:  J Diabetes Sci Technol       Date:  2016-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.